HK1041444A1 - Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections - Google Patents

Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections

Info

Publication number
HK1041444A1
HK1041444A1 HK02102802.2A HK02102802A HK1041444A1 HK 1041444 A1 HK1041444 A1 HK 1041444A1 HK 02102802 A HK02102802 A HK 02102802A HK 1041444 A1 HK1041444 A1 HK 1041444A1
Authority
HK
Hong Kong
Prior art keywords
asparaginase
peg
treatment
pharmaceutical compositions
hiv infections
Prior art date
Application number
HK02102802.2A
Other languages
Chinese (zh)
Inventor
L Avramis Vassilios
Cohen Lewis
Original Assignee
Enzon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/370,390 external-priority patent/US6689762B1/en
Application filed by Enzon Pharmaceuticals Inc filed Critical Enzon Pharmaceuticals Inc
Publication of HK1041444A1 publication Critical patent/HK1041444A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK02102802.2A 1999-08-06 2002-04-13 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections HK1041444A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/370,390 US6689762B1 (en) 1998-02-09 1999-08-06 Composition and methods for treatment of HIV infection
PCT/US2000/021462 WO2001010454A2 (en) 1999-08-06 2000-08-07 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection

Publications (1)

Publication Number Publication Date
HK1041444A1 true HK1041444A1 (en) 2002-07-12

Family

ID=23459436

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102802.2A HK1041444A1 (en) 1999-08-06 2002-04-13 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections

Country Status (7)

Country Link
EP (1) EP1143990A3 (en)
JP (1) JP2003506409A (en)
AU (1) AU6894400A (en)
CA (1) CA2346063A1 (en)
HK (1) HK1041444A1 (en)
WO (1) WO2001010454A2 (en)
ZA (1) ZA200102506B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911460B2 (en) 2001-04-20 2005-06-28 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
US8029815B2 (en) 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
US9526707B2 (en) 2007-08-13 2016-12-27 Howard L. Elford Methods for treating or preventing neuroinflammation or autoimmune diseases
ES2671478T3 (en) 2012-08-31 2018-06-06 Novartis Ag 2'-ethinyl nucleoside derivatives for the treatment of viral infections
RU2732572C2 (en) * 2016-05-31 2020-09-21 Тайхо Фармасьютикал Ко., Лтд. Sulphonamide compound or salt thereof
US10889555B2 (en) 2016-05-31 2021-01-12 Taiho Pharmaceutical Co., Ltd. Sulfonamide compound or salt thereof
MA51224A (en) * 2017-11-29 2020-10-07 Taiho Pharmaceutical Co Ltd SULFONAMIDE COMPOUNDS AND THEIR USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (en) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES
AU752370B2 (en) * 1997-06-09 2002-09-19 Children's Hospital Of Los Angeles Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence
ZA991029B (en) * 1998-02-09 1999-09-30 Rhone Poulenc Rorer Pharma Composition and methods for treatment of hiv infections.

Also Published As

Publication number Publication date
EP1143990A3 (en) 2002-03-27
WO2001010454A9 (en) 2002-11-07
CA2346063A1 (en) 2001-02-15
EP1143990A2 (en) 2001-10-17
WO2001010454A3 (en) 2002-01-24
WO2001010454B1 (en) 2002-07-11
AU6894400A (en) 2001-03-05
JP2003506409A (en) 2003-02-18
ZA200102506B (en) 2002-03-27
WO2001010454A2 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
IL147756A0 (en) Preserved pharmaceutical formulations
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
GB9923436D0 (en) Pharmaceutical compositions
GB0029936D0 (en) A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation
IL146025A0 (en) Improved pharmaceutical formulations comprising at least one hiv protease inhibiting compound
GB9904163D0 (en) Pharmaceutical compositions
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
HK1041444A1 (en) Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
GB9911017D0 (en) Pharmaceutical compositions
AP2002002432A0 (en) Treatment of viral infections
GB9904911D0 (en) Pharmaceutical compositions
GB9909154D0 (en) Pharmaceutical formulation
GB9902651D0 (en) Pharmaceutical compositions
GB9926251D0 (en) Pharmaceutical formulation
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
GB2362827B (en) Pharmaceutical preparation for treating viral infections
GB0016845D0 (en) Pharmaceutical composition for treatment of HIV infection
IL136687A0 (en) Pharmaceutical composition for the treatment of multiple sclerosis
SI1220858T1 (en) Oxazinoquinolones useful for the treatment of viral infections
HU0003973D0 (en) Pharmaceutical composition for the treatment of aids